Analyst Ratings For NASDAQ:ATRC – AtriCure (NASDAQ:ATRC)
Today, Stifel Nicolaus raised its price target on NASDAQ:ATRC – AtriCure (NASDAQ:ATRC) to $23.00 per share.
Some recent analyst ratings include
- 12/10/2017-Piper Jaffray Reiterated Rating of Buy.
- 6/16/2017-Leerink Swann Reiterated Rating of Outperform.
- 3/20/2017-Northland Securities Reiterated Rating of Buy.
- 3/6/2017-BTIG Research was Downgraded by analysts at BTIG Research from a “Buy ” rating to a ” Neutral” rating.
Recent Insider Trading Activity For NASDAQ:ATRC – AtriCure (NASDAQ:ATRC)
NASDAQ:ATRC – AtriCure (NASDAQ:ATRC) has insider ownership of 10.00% and institutional ownership of 86.23%.
- On 3/13/2018 Elizabeth D Krell, Director, sold 10,000 with an average share price of $20.00 per share and the total transaction amounting to $200,000.00.
- On 3/1/2018 Regina E Groves, Director, bought 1,000 with an average share price of $17.43 per share and the total transaction amounting to $17,430.00.
- On 2/15/2018 Justin J Noznesky, SVP, sold 4,000 with an average share price of $17.03 per share and the total transaction amounting to $68,120.00.
- On 11/30/2017 M. Andrew Wade, CFO, sold 2,000 with an average share price of $18.41 per share and the total transaction amounting to $36,820.00.
- On 11/8/2017 B Kristine Johnson, Director, bought 1,500 with an average share price of $18.36 per share and the total transaction amounting to $27,540.00.
- On 8/22/2017 Elizabeth D Krell, Director, sold 10,000 with an average share price of $22.40 per share and the total transaction amounting to $224,000.00.
- On 5/17/2017 Elizabeth D Krell, Director, sold 10,000 with an average share price of $21.44 per share and the total transaction amounting to $214,400.00.
Recent Trading Activity for NASDAQ:ATRC – AtriCure (NASDAQ:ATRC)
Shares of NASDAQ:ATRC – AtriCure closed the previous trading session at 22.13 up +1.51 7.32% with 89788 shares trading hands.